BAMEA-O16B
BAMEAO16B is a lipid nanoparticle. BAMEAO16B integrated with disulfide bonds, can efficiently deliver Cas9 mRNA and sgRNA into cells while releasing RNA in response to the reductive intracellular environment for genome editing. BAMEAO16B can be used for the research of gene editing[1].
Product Specifications
CAS Number
2490668-30-7
UNSPSC
12352211
Hazard Statement
H225, H302, H319, H336
Target
Liposome
Type
Oligonucleotides
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bamea-o16b.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : ≥ 100 mg/mL|Ethanol : 100 mg/mL (ultrasonic)
Smiles
CN(CCN(CCC(OCCSSCCCCCCCCCCCC)=O)CCC(OCCSSCCCCCCCCCCCC)=O)CCNCCC(OCCSSCCCCCCCCCCCC)=O
Molecular Formula
C56H111N3O6S6
Molecular Weight
1114.89
Precautions
H225, H302, H319, H336
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (101-1D2), CF405S conjugate, 0.1mg/mL
CD54 / ICAM-1 (15.2), CF568 conjugate, 0.1mg/mL
CD50 (ICAM-3) (186-2G9), CF568 conjugate, 0.1mg/mL
CD100 (Semaphorin-4D) (A8), CF405S conjugate, 0.1mg/mL
